Search

everythinglearnresearchcommunity

for

Search:↓

Temporal triangular alopecia may be linked to sebaceous nevus and shows a new pinkish background feature.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

A hand-held dermatoscope helped differentiate between pressure-induced alopecia and alopecia areata in a young patient, who then experienced hair regrowth within a month.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Trichostasis spinulosa is a rare skin condition with hair-filled plugs in hair follicles.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Hair transplant combining scalp and beard hair with PRP was successful for scarring alopecia.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

The combined treatment improved hair growth and scalp health in a patient with scalp alopecia from birth.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

A 17-year-old boy with Temporal Triangular Alopecia successfully grew new hair after a hair restoration surgery using follicular unit transplantation.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

An 18-year-old with hair loss saw hair regrowth after treatments combining microneedling, cupping, medication, and oil application.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Act quickly to treat traction alopecia to prevent permanent hair loss.

Androgenic alopecia causes hair follicle degradation and skin restructuring, but some hair elements remain.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.